Literature DB >> 20713237

Endolymphatic hydrops: pathophysiology and experimental models.

Alec N Salt1, Stefan K Plontke.   

Abstract

It is well established that endolymphatic hydrops plays a role in Ménière disease, even though the precise role is not fully understood and the presence of hydrops in the ear does not always result in symptoms of the disease. It nevertheless follows that a scientific understanding of how hydrops arises, how it affects the function of the ear, and how it can be manipulated or reversed could contribute to the development of effective treatments for the disease. Measurements in animal models in which endolymphatic hydrops has been induced have given numerous insights into the relationships between hydrops and other pathologic and electrophysiological changes, and how these changes influence the function of the ear. The prominent role of the endolymphatic sac in endolymph volume regulation, and the cascade of histopathological and electrophysiological changes that are associated with chronic endolymphatic hydrops, have now been established. An increasing number of models are now available that allow specific aspects of the interrelationships to be studied. The yclical nature of Ménière symptoms gives hope that treatments can be developed to maintain the ear in permanent state of remission, possibly by controlling endolymphatic hydrops, thereby avoiding the rogressive damage and secondary pathologic changes that may also contribute to the patient's symptoms. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713237      PMCID: PMC2923478          DOI: 10.1016/j.otc.2010.05.007

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  76 in total

1.  Responses of the endolymphatic sac to perilymphatic injections and withdrawals: evidence for the presence of a one-way valve.

Authors:  Alec N Salt; Helge Rask-Andersen
Journal:  Hear Res       Date:  2004-05       Impact factor: 3.208

2.  Time-related changes in cochlear potentials in guinea pigs with experimentally induced endolymphatic hydrops.

Authors:  J Kusakari; T Kobayashi; E Arakawa; M Rokugo; K Ohyama
Journal:  Acta Otolaryngol Suppl       Date:  1987

3.  A new aspect in pathogenesis of experimental hydrops: role of calcium.

Authors:  A M Meyer zum Gottesberge; O Ninoyu
Journal:  Aviat Space Environ Med       Date:  1987-09

4.  Saccular and cochlear endolymphatic potentials in experimentally induced endolymphatic hydrops of guinea pigs.

Authors:  J Kusakari; T Kobayashi; E Arakawa; M Rokugo; K Ohyama; N Inamura
Journal:  Acta Otolaryngol       Date:  1986 Jan-Feb       Impact factor: 1.494

5.  Effects of cerebrospinal fluid loss on hearing.

Authors:  A Walsted
Journal:  Acta Otolaryngol Suppl       Date:  2000

6.  Effects of low-sodium, high-potassium dietary intake on cochlear lateral wall Na+,K(+)-ATPase.

Authors:  W J ten Cate; L M Curtis; K E Rarey
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

7.  Detection and quantification of endolymphatic hydrops in the guinea pig cochlea by magnetic resonance microscopy.

Authors:  A N Salt; M M Henson; S L Gewalt; A W Keating; J E DeMott; O W Henson
Journal:  Hear Res       Date:  1995-08       Impact factor: 3.208

8.  Hydrostatic pressure measurements of endolymph and perilymph in a guinea pig model of endolymphatic hydrops.

Authors:  C H Long; T Morizono
Journal:  Otolaryngol Head Neck Surg       Date:  1987-01       Impact factor: 3.497

9.  Endolymphatic hydrops induced by chronic administration of vasopressin.

Authors:  T Takeda; S Takeda; H Kitano; T Okada; A Kakigi
Journal:  Hear Res       Date:  2000-02       Impact factor: 3.208

Review 10.  Otologic manifestations of benign intracranial hypertension syndrome: diagnosis and management.

Authors:  A Sismanis
Journal:  Laryngoscope       Date:  1987-08       Impact factor: 3.325

View more
  36 in total

1.  Osmotic stabilization prevents cochlear synaptopathy after blast trauma.

Authors:  Jinkyung Kim; Anping Xia; Nicolas Grillet; Brian E Applegate; John S Oghalai
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

2.  Chronic cerebrospinal venous insufficiency in patients with Ménière's disease.

Authors:  R Filipo; F Ciciarello; G Attanasio; P Mancini; E Covelli; L Agati; F Fedele; M Viccaro
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-07       Impact factor: 2.503

3.  ELHnet: a convolutional neural network for classifying cochlear endolymphatic hydrops imaged with optical coherence tomography.

Authors:  George S Liu; Michael H Zhu; Jinkyung Kim; Patrick Raphael; Brian E Applegate; John S Oghalai
Journal:  Biomed Opt Express       Date:  2017-09-20       Impact factor: 3.732

Review 4.  Vasopressin receptor antagonists.

Authors:  Biff F Palmer
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

Review 5.  Innovative pharmaceutical approaches for the management of inner ear disorders.

Authors:  Umberto M Musazzi; Silvia Franzé; Francesco Cilurzo
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

6.  MRI of endolymphatic hydrops in patients with Meniere's disease: a case-controlled study with a simplified classification based on saccular morphology.

Authors:  Arnaud Attyé; Michael Eliezer; Naïla Boudiaf; Irène Tropres; David Chechin; Sébastien Schmerber; Georges Dumas; Alexandre Krainik
Journal:  Eur Radiol       Date:  2016-12-20       Impact factor: 5.315

Review 7.  Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

Authors:  Rita Sousa; Francisco Raposo; Carla Guerreiro; David Berhanu; Tiago Eça; J Campos; Leonel Luís
Journal:  Neuroradiology       Date:  2021-06-17       Impact factor: 2.804

8.  Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere's disease: our results.

Authors:  Alfonso Scarpa; Massimo Ralli; Pasquale Viola; Claudia Cassandro; Matteo Alicandri-Ciufelli; Maurizio Iengo; Giuseppe Chiarella; Marco de Vincentiis; Michele Cavaliere; Ettore Cassandro
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-11       Impact factor: 2.503

9.  Endolymphatic space size in patients with vestibular migraine and Ménière's disease.

Authors:  Takafumi Nakada; Tadao Yoshida; Kenji Suga; Masahiro Kato; Hironao Otake; Ken Kato; Masaaki Teranishi; Michihiko Sone; Saiko Sugiura; Kayao Kuno; Ilmari Pyykkö; Shinji Naganawa; Hirohisa Watanabe; Gen Sobue; Tsutomu Nakashima
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

Review 10.  Corticosteroid therapy for hearing and balance disorders.

Authors:  Dennis R Trune; Barbara Canlon
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.